Day trading pre-market open January 28, page-44

An Australian pharmaceutical firm that's developing a world first virus-killing nasal spray is set to list on the ASX.Firebrick Pharma co-founder Dr Peter Molloy told AAP he's been working on the spray, called Nasodine, for almost a decade, as a treatment for the common cold."It appeared to me that if you could kill the viruses that are present in the nose, you could intervene in the course of the common cold and stop it spreading in the body and to other people," he said.

been working on it for a decade. Alot of time and money has already been spent.